MicroRNA associated with dyslipidemia and coronary disease in humans

Elena Flowers, Bradley E. Aouizerat

Research output: Contribution to journalReview articlepeer-review


MicroRNAs are structural components of an epigenetic mechanism of posttranscriptional regulation of messenger RNA translation. Recently, there has been significant interest in the application of microRNA as a blood-based biomarker of underlying physiological conditions. Dyslipidemia is a complex, heterogeneous condition conferring substantially increased risk for cardiovascular disease. The purpose of this review is to describe the current body of knowledge on the role of microRNA regulation of lipoprotein metabolism in humans and to discuss relevant methodological and study design considerations. We highlight the potential roles for microRNA in geneenvironment interactions.

Original languageEnglish (US)
Pages (from-to)1199-1205
Number of pages7
JournalPhysiological Genomics
Issue number24
StatePublished - Dec 15 2013


  • Lipids
  • MicroRNA

ASJC Scopus subject areas

  • Physiology
  • Genetics


Dive into the research topics of 'MicroRNA associated with dyslipidemia and coronary disease in humans'. Together they form a unique fingerprint.

Cite this